Change in left ventricular size and systolic function between weeks 0 and 12
| Metoprolol | Celiprolol | Placebo | ||||||
|---|---|---|---|---|---|---|---|---|
| 0 | 12 | 0 | 12 | 0 | 12 | |||
| LVEF (%) | 26.9 (3.1) | 31 (3.4)3-150 | 30.2 (2.7) | 36.7 (3.8) | 33.1 (4) | 29 (2.8)3-150 | ||
| FS (%) | 14.4 (1.3) | 17 (1.3) | 15 (1.1) | 17.8 (1.5) | 18 (1.5) | 19 (2.2) | ||
| LVEDD (cm) | 7.2 (0.3) | 7.2 (0.2) | 6.9 (0.3) | 6.7 (0.3) | 6.7 (0.2) | 6.8 (0.2) | ||
Values are mean (SEM).
↵3-150 p < 0.05.
FS, fractional shortening; LVEDD, left ventricular end diastolic dimension; LVEF, left ventricular ejection fraction.